email article
Smart home speakers like Amazon Echo can be used to monitor heart rhythms by sonar, researchers report in
Communications Biology.
The ACTIV-4 Convalescent trial is now underway testing apixaban (Eliquis) for thromboprophylaxis after discharge for moderate-to-severe COVID-19, the NIH announced.
Even if heart failure stabilizes without improving on cardiac resynchronization therapy, 5-year prognosis is much better than was thought, suggesting that the current convention of nonresponder classification should be modified, according to a REVERSE trial analysis. (
JACC: Clinical Electrophysiology)
The 4PEPS tool safely ruled out pulmonary embolism solely on clinical criteria and optimized D-dimer measurement, while substantially reducing imaging tests. (